Infliximab in Refractory Uveitis Due to Behcet's Disease: Long Term Follow-up and Therapy Optimization. Multicenter Study of 103 Caucasian Patients

被引：0

作者：

Luis Martin-Varillas, Jose ^{[1
]}

Atienza-Mateo, Belen ^{[2
,3
]}

Calvo-Rio, Vanesa ^{[4
]}

Beltran-Catalan, Emma ^{[5
]}

Adan, Alfredo ^{[6
]}

Hernandez Garfella, Marisa ^{[7
]}

Valls-Pascual, Elia ^{[8
]}

Sellas-Fernandez, Agustin ^{[9
]}

Ortego, N. ^{[10
]}

Fonollosa, Alejandro ^{[11
]}

Maiz Alonso, Olga ^{[12
]}

Torre, Ignacio ^{[13
]}

Fernandez-Espartero, Cruz ^{[14
]}

Jovani, Vega ^{[15
]}

Peiteado, Diana ^{[16
]}

Diaz Valle, David ^{[17
]}

Romero-Yuste, Susana ^{[18
]}

Aurrecoechea, Elena ^{[1
]}

Garcia-Arias, Miriam ^{[19
]}

Angel Caracuel, Miguel ^{[20
]}

Insua, Santos ^{[21
]}

Gonzalez-Suarez, Senen ^{[22
]}

Sanchez Andrade, Amalia ^{[23
]}

Francisco Linares, Luis ^{[24
]}

Garcia Gonzalez, Alfredo J. ^{[25
]}

Almodovar, Raquel ^{[26
]}

Carrasco Cubero, Carmen ^{[27
]}

Alcalde Villar, Maria ^{[28
]}

Fernandez-Carballido, C. ^{[29
]}

Pages, Fred A. ^{[30
]}

Pena Sainz-Pardo, Eva ^{[25
]}

Demetrio-Pablo, Rosalia ^{[4
]}

Castaneda, Santos ^{[31
]}

Angel Gonzalez-Gay, Miguel ^{[32
]}

Luis Hernandez, Jose ^{[4
]}

Blanco, Ricardo ^{[4
]}

机构：

[1] Hosp Sierrallana, Torrelavega, Spain

[2] Hosp Univ Marques Valdecilla, IDIVAL, Res Grp Genet Epidemiol & Atherosclerosis Syst, Santander, Spain

[3] Hosp Univ Marques Valdecilla, Dept Rheumatol, Santander, Spain

[4] Hosp Univ Marques Valdecilla, Santander, Spain

[5] Del Mar Univ Hosp, Barcelona, Spain

[6] Hosp Clin Barcelona, Barcelona, Spain

[7] Hosp Valencia, Valencia, Spain

[8] Hosp Doctor Peset, Valencia, Spain

[9] Hosp Valle De Hebron, Barcelona, Spain

[10] Hosp San Cecilio, Granada, Spain

[11] Hosp De Cruces, Bilbao, Spain

[12] Hosp Univ Donostia, San Sebastian, Pais Vasco, Spain

[13] Hosp Basurto, Bilbao, Spain

[14] Hosp Mostoles, Madrid, Spain

[15] Hosp Alicante, Alicante, Spain

[16] Hosp La Paz IdiPAZ, Madrid, Spain

[17] Hosp Clin San Carlos, Madrid, Spain

[18] Hosp Pontevedra, Coruna, Spain

[19] Hosp La Princesa, Madrid, Spain

[20] Hosp Univ Reina Sofia, Cordoba, Spain

[21] Hosp Santiago De Compostela, Santiago De Compostela, Spain

[22] Hosp Cabuenes, Gijon, Spain

[23] Hosp Lucus Augusti, Lugo, Spain

[24] Hosp Arrixaca, Murcia, Spain

[25] Hosp 12 Octubre, Madrid, Spain

[26] Fdn Alcorcon Univ Hosp, Madrid, Spain

[27] Hosp Merida, Merida, Spain

[28] Hosp Severo Ochoa, Madrid, Spain

[29] Hosp San Juan, Alicante, Spain

[30] Hosp Palencia, Palencia, Spain

[31] Univ Autonoma, Princesa Univ Hosp, Madrid, Spain

[32] Hosp Univ Marques de Valdecilla, Santander, Cantabria, Spain

来源：

ARTHRITIS & RHEUMATOLOGY | 2020年 / 72卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

0406

引用

页数：3

共 50 条

[41] LONG TERM FOLLOW-UP OF BEHCET'S SYNDROME PATIENTS TREATED WITH CYCLOPHOSPHAMIDE
Gurcan, M.
Esatoglu, S. N.
Hamuryudan, V.
Saygin, C.
Saygin, D.
Ugurlu, S.
Seyahi, E.
Fresko, I.
Melikoglu, M.
Yurdakul, S.
Yazici, H.
Hatemi, G.
ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 : 1492 - 1493
[42] Long Term Follow-up of Behcet's Syndrome Patients Treated with Cyclophosphamide
Gurcan, Mert
Esatoglu, Sinem Nihal
Hamuryudan, Vedat
Saygin, Caner
Saygin, Didem
Ugurlu, Serdal
Seyahi, Emire
Melikoglu, Melike
Fresko, Izzet
Yurdakul, Sebahattin
Yazici, Hasan
Hatemi, Gulen
ARTHRITIS & RHEUMATOLOGY, 2017, 69
[43] Long term follow-up of Behcet's syndrome patients treated with cyclophosphamide
Gurcan, M.
Esatoglu, S. N.
Hamuryudan, V.
Saygin, C.
Saygin, D.
Ugurlu, S.
Seyahi, E.
Fresko, I.
Melikoglu, M.
Yurdakul, S.
Yazici, H.
Hatemi, G.
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2018, 36 (06) : S176 - S176
[44] Tocilizumab in Refractory Uveitis Associated with Behcet's Disease. Multicenter Study of 7 Patients
Santos-Gomez, Montserrat
Calvo-Rio, Vanesa
Blanco, Ricardo
Beltran, Emma
Atanes-Sandoval, Antonio
Pons, Enar
Loricera, Javier
Gonzalez-Vela, Carmen
Riancho-Zarrabeitia, Leyre
Palmou, Natalia
Angel Gonzalez-Gay, Miguel
ARTHRITIS & RHEUMATOLOGY, 2015, 67
[45] The effect of biologic therapy different from infliximab or adalimumab in patients with refractory uveitis due to Behcet's disease: results of a multicentre open-label study
Santos-Gomez, M.
Calvo-Rio, V.
Blanco, R.
Beltran, E.
Mesquida, M.
Adan, A.
Cordero-Coma, M.
Garcia-Aparicio, A. M.
Valls Pascual, E.
Martinez-Costa, L.
Hernandez, M. V.
Hernandez Garfella, M.
Gonzalez-Vela, M. C.
Pina, T.
Palmou-Fontana, N.
Loricera, J.
Hernandez, J. L.
Gonzalez-Gay, M. A.
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2016, 34 (06) : S34 - S40
[46] INFLIXIMAB THERAPY FOR CHRONIC PROGRESSIVE NEURO-BEHCET'S DISEASE: A 6-YEAR FOLLOW-UP STUDY
Kikuchi, H.
Kimura, Y.
Asako, K.
Takayama, M.
Kono, H.
Ono, Y.
Hirohata, S.
ANNALS OF THE RHEUMATIC DISEASES, 2013, 71 : 227 - 227
[47] INFLIXIMAB THERAPY FOR CHRONIC PROGRESSIVE NEURO-BEHCET'S DISEASE: A FOUR-YEAR FOLLOW-UP STUDY
Kikuchi, Hirotoshi
Asako, Kurumi
Takayama, Maki
Arinuma, Yoshiyuki
Hirohata, Shunsei
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2010, 28 (04) : S147 - S147
[48] Long Term Follow-up of Infliximab Efficacy in Pulmonary and Extrapulmonary Sarcoidosis Refractory to Conventional Therapy.
Russell, Eric
O'Connor, Carolyn R.
Hussain, Humaira
ARTHRITIS AND RHEUMATISM, 2011, 63 (10): : S768 - S768
[49] Stem cell therapy in refractory perineal Crohn's disease: long-term follow-up
Wainstein, C.
Quera, R.
Fluxa, D.
Kronberg, U.
Conejero, A.
Lopez-Kostner, F.
Jofre, C.
Zarate, A. J.
COLORECTAL DISEASE, 2018, 20 (03) : O68 - O75
[50] MONTHLY INTRAVITREAL INFLIXIMAB IN BEHcET'S DISEASE ACTIVE POSTERIOR UVEITIS A Long-Term Safety Study
Refaat, Mohammad
Abdullatif, Abdussalam M.
Hamza, Mostafa M.
Macky, Tamer A.
El-Agha, Mohamed-Sameh H.
Ragab, Gaafar
Soliman, Mahmoud M.
RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2021, 41 (08): : 1739 - 1747

← 1 2 3 4 5 →